Form D — OS Therapies Inc
0000921895-26-002846 · filed Oct 23, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $12,282,478
- Reported amount sold
- $7,172,429
- Minimum investment
- $0
- Investors
- 9
- Sales commission
- $859,774
- Finders' fees
- $0
Issuer
- Name
- OS Therapies Inc
- CIK
- 1795091
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 115 Pullman Crossing Road
Grasonville, MD 21638 - Phone
- 410-297-7793
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Paul A. Romness · Executive OfficerGrasonville, MD Find on LinkedIn ↗
-
Robert G. Petit · Executive OfficerGrasonville, MD Find on LinkedIn ↗
-
Francis Knuettel II · Executive OfficerGrasonville, MD Find on LinkedIn ↗
-
John Ciccio · DirectorGrasonville, MD Find on LinkedIn ↗
-
Avril McKean Dieser · DirectorGrasonville, MD Find on LinkedIn ↗
-
Craig Eagle · DirectorGrasonville, MD Find on LinkedIn ↗
-
Olivier Jarry · DirectorGrasonville, MD Find on LinkedIn ↗
-
Theodore F. Search · DirectorGrasonville, MD Find on LinkedIn ↗
-
Kerry Clem · Executive OfficerGrasonville, MD Find on LinkedIn ↗
Other filings from this issuer
- Form D — Aug 25, 2026 — 0000921895-26-002306
- Form D — Jul 16, 2026 — 0001795091-26-000003
- Form D — Mar 6, 2026 — 0001795091-26-000002
- Form D — Jan 20, 2026 — 0001795091-26-000001
- Form D — Sep 10, 2025 — 0000921895-25-002566
- Form D — Jul 16, 2025 — 0000921895-25-002001
- Form D — Jan 22, 2025 — 0001795091-25-000004
View the original filing on SEC EDGAR ↗